NCT00000665View on ClinicalTrials.gov

Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

Not specified

Primary Completion Date

April 30, 1992

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Foscarnet sodium

DRUG

Ganciclovir

Trial Locations (9)

10016

New York Univ Med Ctr / SOCA, New York

10021

New York Hosp - Cornell Med Ctr / Sloan - Kettering / SOCA, New York

60611

Northwestern Univ / SOCA, Chicago

70112

Charity Hosp / Tulane Univ Med School, New Orleans

94143

UCSF - San Francisco Gen Hosp, San Francisco

100296574

Mount Sinai Med Ctr / SOCA, New York

212879217

Johns Hopkins Hosp / SOCA, Baltimore

900957003

UCLA - Jules Stein Eye Institute / SOCA, Los Angeles

920930946

UCSD - Shiley Eye Ctr / SOCA, La Jolla

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000665 - Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component | Biotech Hunter | Biotech Hunter